Albany, NY -- (SBWIRE) -- 11/28/2016 -- Some of the major factors which are driving the clinical diagnosis automation market include: growing number of diagnosis globally, low reimbursement rates and growing number of suppliers in the diagnostic market. Many players in the clinical diagnostics market, due to intense competition are looking to sustain in the market by gaining some competitive advantage over each other. These players are focusing on cutting down the overall cost and are putting pressure on laboratories to increase their efficiency and productivity. Automation is proving very fruitful in order to increase the production as well as efficiency.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1105
In Clinical diagnosis automation market by types automated analyzers is the leading clinical diagnosis automation type, whereas Stand-alone automation is the fastest growing type in the clinical diagnosis automation market which is expected to grow at a double digit CAGR throughout the forecasted period. Total lab automation is best suited for large hospitals but due to its properties like inflexibility and the communication problems which add on to the overall cost it is having low market penetration and is serving to only few markets.
Some of the major players in the market include: Abott Diagnostics, Beckman Coulter Inc, Bio-Rad Laboratories Inc, Caliper Life Sciences, Siemens Healthcare and others.